Therapeutic Approaches and Targets for Viral Infections

DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.

Antiviral Drugs :

  • oseltamivir phosphate (available as a generic version or under the trade name Tamiflu®),
  • zanamivir (trade name Relenza®)
  • peramivir (trade name Rapivab®), and.
  • baloxavir marboxil (trade name Xofluza®)

 

    Related Conference of Therapeutic Approaches and Targets for Viral Infections

    October 24-25, 2022

    17th World Congress on Virology, Emerging Diseases & Vaccines

    Zurich, Switzerland
    November 08-09, 2022

    7th Rare Diseases and Orphan Drugs

    London, UK
    November 21-22, 2022

    World Summit on Rare Disease

    Rome, Italy
    December 12-13, 2022

    5th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    January 23-24, 2023

    10th International Congress on Infectious Diseases

    Barcelona, Spain
    February 20-21, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    August 08-09, 2023

    19th World Congress on Infection Prevention and Control

    Zurich, Switzerland
    September 27-28, 2023

    32nd International Conference on Coronary Diseases

    Zurich, Switzerland

    Therapeutic Approaches and Targets for Viral Infections Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in